Kurstjens Sef 4
4 · Urovant Sciences Ltd. · Filed Nov 26, 2018
Insider Transaction Report
Form 4
Kurstjens Sef
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-11-21+36,650→ 36,650 totalExercise: $8.01Exp: 2028-11-21→ Common Shares (36,650 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest and become exercisable in three equal annual installments beginning on November 9, 2019, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.